Cylicin-1 Inhibitors
Cylicin-1 inhibitors are chemical compounds designed to specifically target and inhibit the activity of cylicin-1, a cytoskeletal protein primarily associated with the structure and organization of the sperm head in mammals. Cylicin-1 belongs to the class of basic proteins found in the perinuclear theca, a specialized cytoskeletal structure in sperm cells that plays a crucial role in maintaining the integrity and shape of the sperm head. This protein is essential for stabilizing the head shape, contributing to the proper function of sperm during fertilization. By inhibiting cylicin-1, these compounds interfere with the protein's ability to maintain cytoskeletal organization, potentially affecting the structural integrity of sperm cells.
The study of cylicin-1 inhibitors enables researchers to investigate the specific role of this protein in the formation and maintenance of cytoskeletal structures in sperm cells. Inhibiting cylicin-1 provides valuable insights into how the disruption of cytoskeletal proteins impacts cellular morphology, particularly in highly specialized cells like sperm that require precise structural organization for their function. These inhibitors are also useful in understanding the broader aspects of cytoskeletal dynamics and the molecular interactions that regulate the architecture of cell structures beyond sperm cells. By applying cylicin-1 inhibitors in experimental studies, scientists can explore the protein's contribution to cytoskeletal organization and its role in processes like cellular stability, morphology, and motility. These inhibitors thus serve as important tools for studying cytoskeletal regulation and the complex network of interactions that underpin cellular structure and function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine may cause hypomethylation of the cylicin-1 gene's promoter region, potentially leading to the downregulation of its expression due to altered transcription factor binding. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A can lead to hyperacetylation of histones near the cylicin-1 gene, which may result in decreased transcription and subsequent lower levels of Cylicin-1 protein. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid could activate retinoic acid receptors that bind to the regulatory regions of the cylicin-1 gene, potentially decreasing its expression during spermatogenesis. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin may downregulate cylicin-1 expression by inhibiting the mTOR pathway, which is crucial for protein synthesis and testicular germ cell development. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to DNA and may block the transcription initiation complex formation on the cylicin-1 gene, leading to reduced mRNA and protein levels. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide could directly inhibit the elongation step of mRNA translation, possibly leading to a decrease in Cylicin-1 protein synthesis in testicular cells. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Mycophenolic acid may deplete guanosine nucleotides, potentially leading to the suppression of RNA synthesis, including the transcription of the cylicin-1 gene. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine might inhibit lysosomal degradation pathways, which could lead to altered cellular signaling and a subsequent decrease in cylicin-1 gene expression. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 could block the recruitment of transcription machinery to the promoter region of the cylicin-1 gene by inhibiting BET bromodomain proteins, leading to reduced expression. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Gefitinib may inhibit the epidermal growth factor receptor (EGFR), which could reduce the expression of downstream targets, potentially including the cylicin-1 gene. | ||||||